Enot, Julyve C.

HRN: 14-88-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
CEFUROXIME 500MG (TAB)
05/29/2022
06/05/2022
PO
500mg
Q12
NSVD W/ 3rd Degree Laceration; UTI
Waiting Final Action 
05/30/2022
CO-AMOXICLAV 625MG (TAB)
05/30/2022
06/06/2022
PO
625mg
Q12
UTI; S/P Repair Of 3rd Degree Laceration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: